Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Tumor response as defined by iRECIST in gastrointestinal malignancies treated with PD-1 and PD-L1 inhibitors and correlation with survival

Fig. 4

Kaplan–Meier analysis of changes in OS and tumor diameter in patients. Compared with baseline, the OS in the tumor diameter increase of the < 20% group was longer than that in the tumor diameter increase of the ≥20% group. (A) Overall survival in the cohorts of advanced gastrointestinal cancer patients. (B) Overall survival of patients with colorectal cancer

Back to article page